Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions
Clinical trial NCT00375427 · COMPLETED
Trial details
- NCT number
- NCT00375427
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2010-02-01
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.